Evidence map›Paper›PMID 34768321›Full record

ReviewJournal of clinical medicine2021

Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients.

Mahdie Rahban, Agata Stanek, Amirreza Hooshmand, Yasaman Khamineh, Salma Ahi, Syed Naqui Kazim, Faizan Ahmad, Vladimir Muronetz, Mohamed Samy Abousenna, Samaneh Zolghadri and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 5 countries.

Mahdie RahbanInstitute of Biochemistry and Biophysics, University of Tehran, Tehran 1417614335, Iran.
Agata StanekDepartment of Internal Medicine, Angiology and Physical Medicine, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Batorego 15 St., 41-902 Bytom, Poland.ORCID 0000-0001-6939-9898
Amirreza HooshmandYoung Researchers and Elite Club, Jahrom Branch, Islamic Azad University, Jahrom 7414785318, Iran.ORCID 0000-0001-7963-3131
Yasaman KhaminehYoung Researchers and Elite Club, Jahrom Branch, Islamic Azad University, Jahrom 7414785318, Iran.ORCID 0000-0002-9583-3632
Salma AhiResearch Center for Noncommunicable Diseases, Jahrom University of Medical Sciences, Jahrom 7414846199, Iran.ORCID 0000-0001-9622-2895
Syed Naqui KazimCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India.ORCID 0000-0002-4248-0511
Faizan AhmadCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India.
Vladimir MuronetzBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.
Mohamed Samy AbousennaCentral Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center, Cairo 11517, Egypt.ORCID 0000-0003-2202-9544
Samaneh ZolghadriDepartment of Biology, Jahrom Branch, Islamic Azad University, Jahrom 7414785318, Iran.ORCID 0000-0003-4060-328X
Ali A SabouryInstitute of Biochemistry and Biophysics, University of Tehran, Tehran 1417614335, Iran.ORCID 0000-0003-0604-9465
Islamic Azad University, Jahrom Branch · IRJamia Millia Islamia · INUniversity of Tehran · IRCentral Laboratory For Agricultural Expert Systems · EGJahrom University of Medical Sciences · IRLomonosov Moscow State University · RUMedical University of Silesia · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gastrointestinal tract is the body's largest interface between the host and the external environment. People infected with SARS-CoV-2 are at higher risk of microbiome alterations and severe diseases. Recent evidence has suggested that the pathophysiological and molecular mechanisms associated with gastrointestinal complicity in SARS-CoV-2 infection could be explained by the role of angiotensin-converting enzyme-2 (ACE2) cell receptors. These receptors are overexpressed in the gut lining, leading to a high intestinal permeability to foreign pathogens. It is believed that SARS-CoV-2 has a lesser likelihood of causing liver infection because of the diminished expression of ACE2 in liver cells. Interestingly, an interconnection between the lungs, brain, and gastrointestinal tract during severe COVID-19 has been mentioned. We hope that this review on the molecular mechanisms related to the gastrointestinal disorders as well as neurological and hepatic manifestations experienced by COVID-19 patients will help scientists to find a convenient solution for this and other pandemic events.

Indexed as

angiotensin-converting enzyme-2coronavirus disease 19gut florahepatic derangementsneurological symptomsspike protein

Identifiers

PMID34768321
PMCPMC8584649
OpenAlexW3205365352

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.